13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-10, with 29 holding rows worth $525,486,000.
- Accession
- 0001567619-21-002685
- Filer
- CIK 1475373
- Filed
- 2021-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 29 entries on the cover page, a total value of $525,486,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $525,486,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 838,140 | $48,830,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 578,211 | $47,298,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 351,629 | $30,585,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 121,845 | $30,488,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 237,523 | $27,823,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 690,282 | $24,816,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 147,827 | $23,096,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 361,343 | $22,414,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 593,250 | $21,838,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 143,931 | $20,654,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 320,992 | $18,149,000 | thousands by filing date | |
| BRUKER CORP | 116794108 | COM | 327,477 | $17,726,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 152,640 | $16,713,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 235,818 | $16,106,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 65,585 | $16,059,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 290,850 | $15,578,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 47,360 | $15,207,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 72,064 | $14,669,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 255,360 | $14,384,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 201,230 | $13,323,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 21,417 | $12,485,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 194,012 | $11,647,000 | thousands by filing date | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 368,291 | $11,295,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 64,210 | $10,560,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 167,922 | $7,509,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,598,649 | $5,595,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 35,000 | $5,508,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 29,615 | $3,849,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 11,500 | $1,282,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-21-002685 | this filing | 2021-02-10 | acceptance time not in the bulk data set |